[HTML][HTML] Exploiting the neonatal crystallizable fragment receptor to treat kidney disease

JF Dylewski, G Haddad, J Blaine - Kidney international, 2024 - Elsevier
The neonatal crystallizable fragment receptor (FcRn) was initially discovered as the receptor
that allowed passive immunity in newborns by transporting maternal IgG through the …

New therapies for highly sensitized patients on the waiting list

A Vo, N Ammerman, SC Jordan - Kidney360, 2024 - journals.lww.com
Purpose: Exposure to HLA alloantigens through pregnancy, blood products and previous
transplantations induce powerful immunologic responses that create an immunologic barrier …

Prolonged xenokidney graft survival in sensitized NHP recipients by expression of multiple human transgenes in a triple knockout pig

M Manook, D Olaso, I Anwar, I DeLaura… - Science Translational …, 2024 - science.org
Genetic modification of porcine donors, combined with optimized immunosuppression, has
been shown to improve outcomes of experimental xenotransplant. However, little is known …

The impact of IdeS (imlifidase) on allo‐specific, xeno‐reactive, and protective antibodies in a sensitized rhesus macaque model

I DeLaura, J Zikos, IJ Anwar, J Yoon… - …, 2024 - Wiley Online Library
Background Highly sensitized patients face many barriers to kidney transplantation,
including higher rates of antibody‐mediated rejection after HLA‐incompatible transplant …

Addition of interleukin‐6 receptor blockade to carfilzomib‐based desensitization in a highly sensitized nonhuman primate model

IJ Anwar, B Ezekian, I DeLaura… - American Journal of …, 2022 - Wiley Online Library
Sensitized patients, those who had prior exposure to foreign human leukocyte antigens, are
transplanted at lower rates due to challenges in finding suitable organs. Desensitization …

Advances in desensitization for human leukocyte antigen incompatible kidney transplantation

A Vo, N Ammerman, SC Jordan - Current Opinion in Organ …, 2024 - journals.lww.com
Advances in desensitization for human leukocyte antigen inco... : Current Opinion in Organ
Transplantation Advances in desensitization for human leukocyte antigen incompatible kidney …

Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model

R Schmitz, M Manook, Z Fitch, I Anwar… - Frontiers in …, 2023 - frontiersin.org
Introduction One-third of HLA-incompatible kidney transplant recipients experience antibody
mediated rejection (AMR) with limited treatment options. This study describes a novel …

[HTML][HTML] Translation of therapeutic strategies to modulate B cell reponses from non-human primate models to human kidney transplantation

S Knechtle, J Kwun, S Song, A Jackson… - Frontiers in …, 2023 - frontiersin.org
Using novel drugs targeting lymphocyte costimulation, cytokines, antibody, complement, and
plasma cells, we have developed strategies in a non-human primate model to modulate the …

Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant

M Manook, D Olaso, IJ Anwar, J Yoon, I Delaura… - Science …, 2023 - science.org
Among sensitized patients awaiting a transplant, females are disproportionately
represented, partly because of pregnancy-induced sensitization. Using female NHPs …

Biologics and Biosimilars 101: Principles and Practice

HG Xie - Biologics and Biosimilars, 2022 - taylorfrancis.com
The biological products are mainly composed of biologics, biosimilars, and interchangeable
products (biosimilar themselves) and are categorized as a class of bioactive …